State of New Jersey Common Pension Fund D Purchases 2,199 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

State of New Jersey Common Pension Fund D lifted its position in shares of ICU Medical, Inc. (NASDAQ:ICUIGet Rating) by 17.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,767 shares of the medical instruments supplier’s stock after acquiring an additional 2,199 shares during the period. State of New Jersey Common Pension Fund D owned approximately 0.06% of ICU Medical worth $2,224,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Comerica Bank lifted its holdings in shares of ICU Medical by 60.1% during the 3rd quarter. Comerica Bank now owns 18,156 shares of the medical instruments supplier’s stock worth $2,575,000 after acquiring an additional 6,813 shares during the period. Raymond James & Associates increased its position in ICU Medical by 31.0% during the 3rd quarter. Raymond James & Associates now owns 100,181 shares of the medical instruments supplier’s stock worth $15,087,000 after purchasing an additional 23,679 shares in the last quarter. Raymond James Financial Services Advisors Inc. increased its position in ICU Medical by 85.4% during the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 5,841 shares of the medical instruments supplier’s stock worth $880,000 after purchasing an additional 2,690 shares in the last quarter. Louisiana State Employees Retirement System acquired a new position in ICU Medical during the 3rd quarter worth approximately $798,000. Finally, Boston Trust Walden Corp increased its position in ICU Medical by 3.8% during the 3rd quarter. Boston Trust Walden Corp now owns 239,935 shares of the medical instruments supplier’s stock worth $36,134,000 after purchasing an additional 8,736 shares in the last quarter. Institutional investors own 93.88% of the company’s stock.

Insider Buying and Selling

In related news, VP Virginia Ruth Sanzone sold 325 shares of the stock in a transaction on Tuesday, November 15th. The shares were sold at an average price of $160.12, for a total transaction of $52,039.00. Following the transaction, the vice president now directly owns 3,046 shares of the company’s stock, valued at $487,725.52. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 7.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on ICUI shares. KeyCorp decreased their price target on shares of ICU Medical from $225.00 to $200.00 in a research report on Tuesday, November 8th. StockNews.com upgraded shares of ICU Medical from a “sell” rating to a “hold” rating in a research report on Thursday, November 17th. Finally, Raymond James cut shares of ICU Medical from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 8th.

ICU Medical Trading Down 0.2 %

ICUI opened at $176.82 on Wednesday. ICU Medical, Inc. has a twelve month low of $128.90 and a twelve month high of $251.73. The company has a quick ratio of 1.17, a current ratio of 2.45 and a debt-to-equity ratio of 0.81. The company has a fifty day moving average of $159.38 and a 200-day moving average of $159.96. The stock has a market cap of $4.24 billion, a PE ratio of -113.35 and a beta of 0.53.

ICU Medical (NASDAQ:ICUIGet Rating) last issued its earnings results on Monday, November 7th. The medical instruments supplier reported $1.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.15 by $0.38. The business had revenue of $597.86 million for the quarter, compared to analyst estimates of $562.90 million. ICU Medical had a negative net margin of 1.90% and a positive return on equity of 6.51%. On average, sell-side analysts predict that ICU Medical, Inc. will post 5.18 EPS for the current year.

ICU Medical Profile

(Get Rating)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs.

Recommended Stories

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.